Back to Journals » Biologics: Targets and Therapy
Biologics: Targets and Therapy
ISSN: 1177-5491

Editor-in-Chief: Dr Doris Mangiaracina Benbrook
ISSN: 1177-5475 (Print) - went to online only in 2009
An international, peer reviewed journal focusing on the patho-physiological rationale for, and clinical application of, Biologic agents and their Biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Indexed online:
- Emerging Sources Citation Index (ESCI), from 2016
- PubMed and PubMed Central (Biologics)
- Embase, from 2009 (Correct as at December 8, 2016)
- Scopus, from 2009 (Correct as at December 8, 2016)
- Directory of Open Access Journals (DOAJ)
- OAIster: The Open Access Initiative
Articles:
- View all (431)
- Volume 15, 2021 (10)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Latest articles:
- 5 records -
Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
Hawkins ER, D'Souza RR, Klampatsa A
Biologics: Targets and Therapy 2021, 15:95-105
Published Date: 14 April 2021
Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7
Kubota-Koketsu R, Yunoki M, Okuno Y, Ikuta K
Biologics: Targets and Therapy 2021, 15:87-94
Published Date: 13 April 2021
Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon
O'Donnell KL, Marzi A
Biologics: Targets and Therapy 2021, 15:79-86
Published Date: 18 March 2021
The Current Status of Gene Therapy for the Treatment of Cancer
Belete TM
Biologics: Targets and Therapy 2021, 15:67-77
Published Date: 18 March 2021
Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature
Bounia CA, Theodoropoulou EN, Liossis SNC
Biologics: Targets and Therapy 2021, 15:61-66
Published Date: 17 March 2021